We are live on ! Find out more
MTFB

Motif Bio plc ADRs
MTFB

Delisted

MTFB was delisted on the 16th of December, 2019.

Back to rankings

2 hedge funds and large institutions have $8.81M invested in Motif Bio plc ADRs in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less capital invested

Capital invested by funds: $10.4M → $8.81M (-$1.57M)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.96K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
1
Invesco
Georgia
$8.79M – – –
UBS Group
2
UBS Group
Switzerland
$15K +$2.96K +318 +21%
TRCT
3
Tower Research Capital (TRC)
New York
– -$1K -100 Closed

MTFB Hedge Fund Activity: Q2 2018 in Review

2 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q2 2018, worth a combined $8.81M — down 15% from $10.4M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MTFB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $2.96K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.

  • 2 institutional investors held Motif Bio plc ADRs (MTFB) as of Q2 2018, down from 3 in Q1 2018.
  • Funds reported $8.81M of Motif Bio plc ADRs stock for Q2 2018, down 15% quarter-over-quarter.
  • 0 funds opened new Motif Bio plc ADRs positions in Q2 2018 and 1 closed out, a net change of -1 holder.
  • The largest Motif Bio plc ADRs buyer in Q2 2018 was UBS Group, an estimated $2.96K added.
  • The largest Motif Bio plc ADRs seller in Q2 2018 was Tower Research Capital (TRC), an estimated $1K sold.

Based on aggregated 13F filings for Q2 2018.